Sponsor Pipeline

Multitude Therapeutics Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
7
Active Trials
5
Recruiting
1
Phase 3
4
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-07-22 NCT07718737 Global, Multicenter Study of AMT-116 Versus Investigator's Choice in Participants With… Phase 2/3 Not Yet Recruiting
Active Trials by Phase
Phase 2/3
1
Phase 2
1
Phase 1/2
3
Phase 1
1
Early Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 2/3
NCT07718737 Global, Multicenter Study of AMT-116 Versus Investigator's Choice in Participants With… NSCLC (Advanced Non-small Cell Lung Cancer) Not Yet Recruiting
Phase 2
NCT07474727 A Phase II Study of AMT-676 Combination Therapies in Advanced Colorectal Cancer Colorectal Cancer Not Yet Recruiting
Phase 1/2
NCT06782334 AMT-116 in Patients with Solid Tumors Advanced Solid Tumors Recruiting
NCT06209580 AMT-253 in Patients With Advanced Solid Tumours Malignant Melanoma Recruiting
NCT07590531 AMT-116 in Combination With AK112 in Patients With Lung Cancer Advanced Non-small Cell Lung Cancer (NSCLC) Recruiting
Phase 1
NCT05725291 AMT-116 in Patients With Advanced Solid Tumors Advanced Solid Tumor Recruiting
Early Phase 1
NCT06400485 AMT-676 in Patients With Advanced Solid Tumors Advanced Solid Tumors Recruiting
Disease Areas
Get alerts when Multitude Therapeutics Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free